BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31555905)

  • 1. Biallelic variants in AGMO with diminished enzyme activity are associated with a neurodevelopmental disorder.
    Okur V; Watschinger K; Niyazov D; McCarrier J; Basel D; Hermann M; Werner ER; Chung WK
    Hum Genet; 2019 Dec; 138(11-12):1259-1266. PubMed ID: 31555905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkylglycerol monooxygenase, a heterotaxy candidate gene, regulates left-right patterning via Wnt signaling.
    Duncan AR; González DP; Del Viso F; Robson A; Khokha MK; Griffin JN
    Dev Biol; 2019 Dec; 456(1):1-7. PubMed ID: 31398317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylglycerol monooxygenase as a potential modulator for PAF synthesis in macrophages.
    Tokuoka SM; Kita Y; Shindou H; Shimizu T
    Biochem Biophys Res Commun; 2013 Jun; 436(2):306-12. PubMed ID: 23743196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alkylglycerol monooxygenase (AGMO) gene previously involved in autism also causes a novel syndromic form of primary microcephaly in a consanguineous Saudi family.
    Alrayes N; Mohamoud HS; Ahmed S; Almramhi MM; Shuaib TM; Wang J; Al-Aama JY; Everett K; Nasir J; Jelani M
    J Neurol Sci; 2016 Apr; 363():240-4. PubMed ID: 27000257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate specificity of O-alkylglycerol monooxygenase (E.C. 1.14.16.5), solubilized from rat liver microsomes.
    Kötting J; Unger C; Eibl H
    Lipids; 1987 Nov; 22(11):831-5. PubMed ID: 3444374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A continuous assay for O-alkylglycerol monooxygenase (E.C. 1.14.16.5).
    Koetting J; Unger C; Eibl H
    Lipids; 1987 Nov; 22(11):824-30. PubMed ID: 3444373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome Sequencing Identifies Two Variants of the Alkylglycerol Monooxygenase Gene as a Cause of Relapses in Visceral Leishmaniasis in Children, in Sudan.
    Marquet S; Bucheton B; Reymond C; Argiro L; El-Safi SH; Kheir MM; Desvignes JP; Béroud C; Mergani A; Hammad A; Dessein AJ
    J Infect Dis; 2017 Jul; 216(1):22-28. PubMed ID: 28586473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recessive Rare Variants in Deoxyhypusine Synthase, an Enzyme Involved in the Synthesis of Hypusine, Are Associated with a Neurodevelopmental Disorder.
    Ganapathi M; Padgett LR; Yamada K; Devinsky O; Willaert R; Person R; Au PB; Tagoe J; McDonald M; Karlowicz D; Wolf B; Lee J; Shen Y; Okur V; Deng L; LeDuc CA; Wang J; Hanner A; Mirmira RG; Park MH; Mastracci TL; Chung WK
    Am J Hum Genet; 2019 Feb; 104(2):287-298. PubMed ID: 30661771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Physiological Role of AGMO 10 Years after Its Gene Identification.
    Sailer S; Keller MA; Werner ER; Watschinger K
    Life (Basel); 2021 Jan; 11(2):. PubMed ID: 33530536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDV Syndrome: An Emerging Syndrome With Profound Obesity and Neurodevelopmental Delay Resembling Prader-Willi Syndrome.
    Bosch E; Hebebrand M; Popp B; Penger T; Behring B; Cox H; Towner S; Kraus C; Wilson WG; Khan S; Krumbiegel M; Ekici AB; Uebe S; Trollmann R; Woelfle J; Reis A; Vasileiou G
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3413-3427. PubMed ID: 34383079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic USP14 variants cause a syndromic neurodevelopmental disorder.
    Ebstein F; Latypova X; Sharon Hung KY; Prado MA; Lee BH; Möller S; Wendlandt M; Zieba BA; Florenceau L; Vignard V; Poirier L; Toutain B; Moroni I; Dubucs C; Chassaing N; Horvath J; Prokisch H; Küry S; Bézieau S; Paulo JA; Finley D; Krüger E; Ghezzi D; Isidor B
    Genet Med; 2024 Jun; 26(6):101120. PubMed ID: 38469793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biallelic variants in
    Maroofian R; Sedmík J; Mazaheri N; Scala M; Zaki MS; Keegan LP; Azizimalamiri R; Issa M; Shariati G; Sedaghat A; Beetz C; Bauer P; Galehdari H; O'Connell MA; Houlden H
    J Med Genet; 2021 Jul; 58(7):495-504. PubMed ID: 32719099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptations of the 3T3-L1 adipocyte lipidome to defective ether lipid catabolism upon Agmo knockdown.
    Sailer S; Lackner K; Pras-Raves ML; Wever EJM; van Klinken JB; Dane AD; Geley S; Koch J; Golderer G; Werner-Felmayer G; Keller MA; Zwerschke W; Vaz FM; Werner ER; Watschinger K
    J Lipid Res; 2022 Jun; 63(6):100222. PubMed ID: 35537527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGMO Inhibitor Reduces 3T3-L1 Adipogenesis.
    Fischer C; Wilken-Schmitz A; Hernandez-Olmos V; Proschak E; Stark H; Fleming I; Weigert A; Thurn M; Hofmann M; Werner ER; Geisslinger G; Niederberger E; Watschinger K; Tegeder I
    Cells; 2021 May; 10(5):. PubMed ID: 34062826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipodisqs for eukaryote lipidomics with retention of viability: Sensitivity and resistance to Leucobacter infection linked to C.elegans cuticle composition.
    Bada Juarez JF; O'Rourke D; Judge PJ; Liu LC; Hodgkin J; Watts A
    Chem Phys Lipids; 2019 Aug; 222():51-58. PubMed ID: 31102583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
    Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
    Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When the genome bluffs: a tandem duplication event during generation of a novel Agmo knockout mouse model fools routine genotyping.
    Sailer S; Coassin S; Lackner K; Fischer C; McNeill E; Streiter G; Kremser C; Maglione M; Green CM; Moralli D; Moschen AR; Keller MA; Golderer G; Werner-Felmayer G; Tegeder I; Channon KM; Davies B; Werner ER; Watschinger K
    Cell Biosci; 2021 Mar; 11(1):54. PubMed ID: 33726865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the gene encoding alkylglycerol monooxygenase defines a third class of tetrahydrobiopterin-dependent enzymes.
    Watschinger K; Keller MA; Golderer G; Hermann M; Maglione M; Sarg B; Lindner HH; Hermetter A; Werner-Felmayer G; Konrat R; Hulo N; Werner ER
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13672-7. PubMed ID: 20643956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bi-allelic variants in OGDHL cause a neurodevelopmental spectrum disease featuring epilepsy, hearing loss, visual impairment, and ataxia.
    Yap ZY; Efthymiou S; Seiffert S; Vargas Parra K; Lee S; Nasca A; Maroofian R; Schrauwen I; Pendziwiat M; Jung S; Bhoj E; Striano P; Mankad K; Vona B; Cuddapah S; Wagner A; Alvi JR; Davoudi-Dehaghani E; Fallah MS; Gannavarapu S; Lamperti C; Legati A; Murtaza BN; Nadeem MS; Rehman MU; Saeidi K; Salpietro V; von Spiczak S; Sandoval A; Zeinali S; Zeviani M; Reich A; ; ; Jang C; Helbig I; Barakat TS; Ghezzi D; Leal SM; Weber Y; Houlden H; Yoon WH
    Am J Hum Genet; 2021 Dec; 108(12):2368-2384. PubMed ID: 34800363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi-allelic PAGR1 variants are associated with microcephaly and a severe neurodevelopmental disorder: Genetic evidence from two families.
    Daum H; Ganapathi M; Hirsch Y; Griffin EL; LeDuc CA; Hagen J; Yagel S; Meiner V; Chung WK; Mor-Shaked H
    Am J Med Genet A; 2022 Jan; 188(1):336-342. PubMed ID: 34585832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.